tetradecanoylphorbol acetate has been researched along with tram 34 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cahalan, MD; Chandy, KG; Grissmer, S; Hansel, W; Miller, MJ; Wulff, H | 1 |
Cahalan, MD; Chandy, KG; Ghanshani, S; Gutman, GA; Miller, MJ; Neben, A; Rohm, H; Wulff, H | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and tram 34
Article | Year |
---|---|
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.
Topics: Calcium Channel Blockers; Calcium Channels; Clotrimazole; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Design; Drug Interactions; Electric Conductivity; Humans; Immunosuppressive Agents; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; Ionomycin; Lymphocyte Activation; Potassium Channels; Pyrazoles; Structure-Activity Relationship; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2000 |
Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.
Topics: Calcium Channel Blockers; Calcium Channels; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Lymphocyte Activation; Mitogens; Models, Biological; Molecular Sequence Data; Phytohemagglutinins; Potassium Channels; Promoter Regions, Genetic; Pyrazoles; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic; Up-Regulation | 2000 |